Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Schizophrenia

3,3',5-triiodothyroacetic acid has been researched along with Schizophrenia in 1 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kunitake, JM1
Hartman, N1
Henson, LC1
Lieberman, J1
Williams, DE1
Wong, M1
Hershman, JM1

Other Studies

1 other study available for 3,3',5-triiodothyroacetic acid and Schizophrenia

ArticleYear
3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 69, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Hyperthyroidism; Lipids; Male; Pituitary Gl

1989